Allgens(SH:688613) Sou Hu Cai Jing·2026-01-09 00:27Group 1 - The stock of Aojing Medical (688613) closed at 22.56 yuan on January 8, 2026, with an increase of 4.44% and a turnover rate of 5.78% [1] - The total trading volume was 79,200 hands, with a transaction amount of 176 million yuan [1] - On January 8, the net inflow of main funds was 26.66 million yuan, accounting for 15.13% of the total transaction amount, while retail investors had a net outflow of 20.43 million yuan, accounting for 11.6% [1] Group 2 - In the financing and securities lending data, the financing buy amounted to 30.56 million yuan, with a net financing increase of 11.78 million yuan [2] - The total financing and securities lending balance was 198 million yuan [2] - Aojing Medical's main business includes the research, production, and sales of high-end biomedical materials and related medical devices [3] Group 3 - For the first three quarters of 2025, Aojing Medical reported a main revenue of 156 million yuan, a year-on-year increase of 5.22%, and a net profit attributable to shareholders of 13.94 million yuan, up 185.19% [3] - In Q3 2025, the company achieved a single-quarter main revenue of 56.02 million yuan, a year-on-year increase of 16.54%, and a net profit of 5.97 million yuan, up 237.64% [3] - The company's debt ratio was 6.22%, with a gross profit margin of 68.9% [3]